RMD News

Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

Rapid Medical™、末梢血管閉塞に対する TIGERTRIEVER 13™ を評価する DISTALS 試験の登録を完了

Rapid Medical™ voltooit inschrijving voor DISTALS-studie ter evaluatie van TIGERTRIEVER 13™ voor distale vaatocclusies

Rapid Medical™ completa l'arruolamento nello studio clinico DISTALS volto a valutare TIGERTRIEVER 13™ nelle occlusioni vascolari distali

Rapid Medical™ termine le recrutement inscription pour l'essai DISTALS évaluant TIGERTRIEVER 13™ pour les occlusions vasculaires distales

Rapid Medical™ cierra la inscripción en la prueba DISTALS, que evalúa a TIGERTRIEVER 13™ para oclusiones de vasos distales

Rapid Medical™ schließt die Rekrutierung für die DISTALS-Studie zur Bewertung von TIGERTRIEVER 13™ bei distalen Gefäßverschlüssen ab

Rapid Medical™ Completes Enrollment in DISTALS Trial Evaluating TIGERTRIEVER 13™ for Distal Vessel Occlusions

Delphia Therapeutics Appoints Leading Cancer Expert Steve Kelsey, M.D., to Board of Directors

Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy